Newsroom

Person wearing purple gloves performing chemical synthesis

News

For decades, tuberculosis (TB) has been one of the deadliest infectious diseases worldwide. Resistant strains of Mycobacterium tuberculosis are particularly problematic, as many established drugs are becoming increasingly ineffective against them. However, a research team from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University has now discovered a new family of natural substances that exhibit excellent activity against the TB pathogen. They have also investigated these substances so comprehensively that targeted further development is possible for the first time. The researchers have now published their findings in the journal Angewandte Chemie International Edition.

21.01.2026

HIPS

News

Two collaborative projects involving the Helmholtz Centre for Infection Research (HZI) are being funded with 100,000 euros each from the joint program "zukunft.niedersachsen" of the state of Lower Saxony and the Volkswagen Foundation. Both projects result from the collaboration between HZI and the MRC–University of Glasgow Centre for Virus Research (CVR), established in 2024 as part of a cooperation between the Helmholtz Association and the British Medical Research Council (MRC). The funded MARITH project will grow organoids from throat tonsil tissue to study the development of immunological memory in humans, while the ViReST project analyzes the sites of viral replication in respiratory infections and their impact on virus transmission.

20.01.2026

HZI Campus

News

The global skin care company Beiersdorf and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have entered into a long-term, exclusive partnership. In this collaboration they aim to investigate the role of the skin microbiome in maintaining healthy skin. The goal is to identify natural products produced by microorganisms on the skin that have a positive effect on skin balance. The project is based on extensive data sets on microorganisms that inhabit human skin.

13.01.2026

HIPS

Cryo-electron microscope image of the nuclease Cas12a3 with illustrated scissors

News

The CRISPR “gene scissors” have become an important basis for genome-editing technologies in many fields, ranging from biology and medicine to agriculture and industry. A team from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now demonstrated that these CRISPR-Cas systems are even more versatile than previously thought. In cooperation with the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Utah State University (USU) in Logan (USA), the scientists have discovered a novel CRISPR defense mechanism: Unlike known nucleases, Cas12a3 specifically destroys transfer ribonucleic acids (tRNA) that are vital for protein production to shut down infected cells. The team published its findings today in the journal Nature.

07.01.2026

HZI Campus

HIRI

News

The gene scissors CRISPR-Cas are an important tool for genome editing. However, their functionality is limited because they rely on specific sequences to operate. Their ancient ancestors, on the other hand, may have been much more versatile. Rediscovering their forgotten abilities and harnessing them for biotechnological applications is the goal of the “RGNcestry” research project led by Chase Beisel, affiliated department head at the Helmholtz Institute for RNA-based Infection Research (HIRI). The European Research Council (ERC) is funding the project with ten million euros over a period of six years.

23.12.2025

HIRI

News

Rare diseases affecting fewer than five in 10,000 people are often particularly difficult to diagnose and treat. As part of their joint funding program “zukunft.niedersachsen”, the state of Lower Saxony and the Volkswagen Foundation have now selected nine promising research projects for funding that aim to develop new diagnoses and treatments for rare diseases. Among them are two projects from the Helmholtz Centre for Infection Research (HZI). The PREDICT-CTP consortium of TWINCORE, the HZI, and Hannover Medical School (MHH) is developing a new diagnostic method for rheumatic diseases. In the StopPSC project, researchers from the HZI and MHH are developing new agents to treat primary sclerosing cholangitis, a chronically progressive inflammation of the bile ducts.

22.12.2025

TWINCORE

HZI Campus

Back to the first page
...
12
13
14
15
...
162

HZI in the media

Mikrobiologen auch Kolleg*innen vom IST Austria und dem HZI in Braunschweig gehören: Inhibitoren von Aktin unterbinden diese dynamischen

01.10.2026

Science.apa.at

... der Medizinischen Hochschule Hannover sowie am Helmholtz-Zentrum für Infektionsforschung tätig ist. Als Co-Autor ist zudem ...

30.09.2026

Ad Hoc News

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

30.09.2026

Phys.org

for cell movement. Scientists from the Helmholtz Center for Infection Research (HZI) in Braunschweig have provided evidence that Profilin

29.09.2026

TakeToNews

Biology (BRICS), a joint research center of the Helmholtz Centre for Infection Research (HZI) and Technische Universität Braunschweig.

29.09.2026

Phys.org

... treffsicher .

Das Helmholtz-Zentrum für Infektionsforschung:

Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) ...

28.09.2026

DeutschesGesundheitsPortal

... Fluorchinolon-Resistenz aktiv

Forscher des Helmholtz-Zentrums für Infektionsforschung (HZI) um Dr. Jennifer Herrmann haben ...

27.09.2026

scinexx - Das Wissensmagazin

Die WHO nennt Antibiotikaresistenzen (AMR) eine der größten globalen Gesundheitsbedrohungen. Bereits heute töten resistente Keime jährlich mehr als eine Million Menschen direkt und tragen zu fast fünf Millionen Todesfällen bei. Tendenz: steigend. Für ein wirkungsvolles Dagegenha

25.09.2026

Sysmex

... die Resistenzen": HZI-Podcast InFact mit Mark Brönstrup

Quelle: Helmholtz-Zentrum für Infektionsforschung (HZI)

Biodiversität ...

25.09.2026

Analytik NEWS

Quelle: Pressemitteilung

Helmholtz-Zentrum für Infektionsforschung

24.09.2026

LaborPraxis

Lange galt Dopamin als simples Glückshormon. Alena Buyx zeigt in ihrer Sendung, dass der Botenstoff ...

24.09.2026

3sat

Leibniz-Lungenzentrum. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit der Universität ...

23.09.2026

DeutschesGesundheitsPortal

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.